BioSyent Inc. (OTCMKTS:BIOYF) Short Interest Down 83.3% in April

BioSyent Inc. (OTCMKTS:BIOYF) was the target of a significant decline in short interest in the month of April. As of April 15th, there was short interest totalling 500 shares, a decline of 83.3% from the March 31st total of 3,000 shares. Based on an average trading volume of 4,700 shares, the days-to-cover ratio is presently 0.1 days.

BioSyent Stock Performance

BIOYF stock remained flat at $6.28 on Thursday. BioSyent has a fifty-two week low of $5.26 and a fifty-two week high of $6.97. The firm has a 50 day moving average of $6.34 and a 200 day moving average of $6.28.

BioSyent Increases Dividend

The firm also recently declared a dividend, which was paid on Friday, March 15th. Shareholders of record on Thursday, February 29th were paid a dividend of $0.0332 per share. The ex-dividend date was Wednesday, February 28th. This represents a yield of 2.08%. This is an increase from BioSyent’s previous dividend of $0.03.

About BioSyent

BioSyent Inc, together with its subsidiaries, acquires or licenses, develops, and sells pharmaceutical and other healthcare products in Canada and internationally. Its products include FeraMAX Pd Therapeutic 150 for the treatment of iron deficiency anemia; FeraMAX Pd Maintenance 45, a chewable supplement for the prevention of iron deficiency anemia; and FeraMAX Pd Powder 15, a powder form product used for preventing iron deficiency and iron deficiency anemia.